{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:46:02Z","timestamp":1791351962527,"version":"4.3.1"},"reference-count":111,"publisher":"Elsevier","isbn-type":[{"value":"9780128112267","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.pmbts.2017.06.010","type":"book-chapter","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T23:15:23Z","timestamp":1502752523000},"page":"293-318","source":"Crossref","is-referenced-by-count":22,"title":["Infectious and Sporadic Prion Diseases"],"prefix":"10.1016","author":[{"given":"Richard","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/bs.pmbts.2017.06.010_bb0010","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt\u2013Jakob disease and related disorders in Europe, Australia and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.06.010_bb0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1086\/505215","article-title":"Creutzfeldt\u2013Jakob disease: a rare cause of dementia in elderly persons","volume":"43","author":"Knight","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"9154","key":"10.1016\/bs.pmbts.2017.06.010_bb0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(98)08138-0","article-title":"Surgical treatment and risk of sporadic Creutzfeldt\u2013Jakob disease: a case\u2013control study","volume":"353","author":"Collins","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.06.010_bb0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.59.4.543","article-title":"Sporadic Creutzfeldt\u2013Jakob disease and surgery: a case\u2013control study using community controls","volume":"59","author":"Ward","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.06.010_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000163097","article-title":"Surgery and risk of sporadic Creutzfeldt\u2013Jakob disease in Denmark and Sweden: registry-based case\u2013control studies","volume":"31","author":"Mahillo-Fernandez","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.06.010_bb0035","first-page":"204","article-title":"Nosocomial transmission of sporadic Creutzfeldt\u2013Jakob disease: results from a risk-based assessment of surgical interventions","volume":"82","author":"de Pedro-Cuesta","year":"2011","journal-title":"JNNP"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0040","first-page":"1113","article-title":"Creutzfeldt\u2013Jakob disease in England and Wales, 1980\u20131984: a case\u2013control study of potential risk factors Harries\u2013Jones et al","volume":"51","author":"Harries-Jones","year":"1988","journal-title":"JNNP"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.06.010_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3201\/eid1502.080749","article-title":"Medical procedures and risk for sporadic Creutzfeldt\u2013Jakob disease, Japan, 1999-2008","volume":"15","author":"Hamaguchi","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.06.010_bb0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bjo.2003.028373","article-title":"Ophthalmic surgery and Creutzfeldt\u2013Jakob disease","volume":"88","author":"Sanchez-Juan","year":"2004","journal-title":"Br J Ophtalmol"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.06.010_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.21294","article-title":"Risk factors for sporadic Creutzfeldt\u2013Jakob disease","volume":"63","author":"Ward","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0060","first-page":"459","article-title":"Geographical distribution of cases of Creutzfeldt\u2013Jakob disease in England and Wales 1970-84","volume":"53","author":"Cousens","year":"1990","journal-title":"JNNP"},{"issue":"11","key":"10.1016\/bs.pmbts.2017.06.010_bb0065","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/01.WNL.0000145844.53251.BC","article-title":"A case\u2013control study of sporadic Creutzfeldt\u2013Jakob disease in the United Kingdom: analysis of clustering","volume":"63","author":"Linsell","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.06.010_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000339318","article-title":"Sensitivity to biases of case\u2013control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt\u2013Jakob disease","volume":"39","author":"de Pedro","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"9109","key":"10.1016\/bs.pmbts.2017.06.010_bb0075","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(97)09468-3","article-title":"Case\u2013control study of risk factors of Creutzfeldt\u2013Jakob disease in Europe during 1993-95. European Union (EU) collaborative study Group of Creutzfeldt\u2013Jakob disease (CJD)","volume":"351","author":"van Duijn","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.06.010_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2350-14-91","article-title":"Splice site SNPs of phospholipase PLCXD3 are significantly associated with variant and sporadic Creutzfeldt\u2013Jakob disease","volume":"14","author":"Bishop","year":"2013","journal-title":"BMC Med Genet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2350-10-146","article-title":"PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism","volume":"10","author":"Bishop","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123654","article-title":"A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt\u2013Jakob disease risk","volume":"10","author":"Sanchez-Juan","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.06.010_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/WAD.0b013e3181ad378c","article-title":"Cathepsin D (C224T) polymorphism and modulation of Creutzfeldt\u2013Jakob disease phenotype","volume":"24","author":"Kovacs","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2350-12-73","article-title":"A polymorphism in the regulatory region of PRNP is associated with increased risk of sporadic Creutzfeldt\u2013Jakob disease","volume":"12","author":"Sanchez-Juan","year":"2011","journal-title":"BMC Med Genet"},{"issue":"8","key":"10.1016\/bs.pmbts.2017.06.010_bb0105","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/hmg\/ddr607","article-title":"Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP","volume":"21","author":"Mead","year":"2012","journal-title":"J Hum Mol Genet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0110","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/jnnp.2006.088930","article-title":"Knight RSG sporadic Creutzfeldt\u2013Jakob disease with cerebellar ataxia at onset in the UK","volume":"77","author":"Cooper","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0115","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bjo.2005.074856","article-title":"Knight RSG isolated visual symptoms at onset in sporadic Creutzfeldt\u2013Jakob disease: the clinical phenotype of the \u201cHeidenhain variant\u201d","volume":"89","author":"Cooper","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.06.010_bb0120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/ane.12600","article-title":"Isolated language impairment as the primary presentation of sporadic Creutzfeldt Jakob disease","volume":"135","author":"Salwa El Tawil","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt\u2013Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0130","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1212\/WNL.53.9.2173","article-title":"Sporadic Creutzfeldt\u2013Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain","volume":"53","author":"Puoti","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-009-0585-1","article-title":"Incidence and spectrum of sporadic Creutzfeldt\u2013Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification","volume":"118","author":"Parchi","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/bs.pmbts.2017.06.010_bb0140","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/brain\/awh249","article-title":"Predictors of survival in sporadic Creutzfeldt\u2013Jakob disease and other human transmissible spongiform encephalopathies","volume":"127","author":"Pocchiari","year":"2004","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/practneurol-2016-001571","article-title":"CJD mimics and chameleons","volume":"17","author":"Mead","year":"2017","journal-title":"Pract Neurol"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.06.010_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1468-1331.2006.01630.x","article-title":"CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies","volume":"14","author":"Green","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0155","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","article-title":"The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt\u2013Jakob disease in the UK: a 10-year review","volume":"81","author":"Chohan","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0160","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/crad.2001.0771","article-title":"MRI of Creutzfeldt\u2013Jakob disease: imaging features and recommended MRI protocol","volume":"56","author":"Collie","year":"2001","journal-title":"Clin Radiol"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.06.010_bb0165","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt\u2013Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0170","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1212\/WNL.0b013e3181a96e5d","article-title":"MRI lesion profiles in sporadic Creutzfeldt\u2013Jakob disease","volume":"72","author":"Meissner","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0175","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt\u2013Jakob disease","volume":"72","author":"McGuire","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0180","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(10)62308-2","article-title":"Detection of prion infection in variant Creutzfeldt\u2013Jakob disease: a blood-based assay","volume":"377","author":"Edgeworth","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.06.010_bb0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaneurol.2013.6001","article-title":"Population screening for variant CJD using a novel blood test. Diagnostic accuracy and feasibility study","volume":"7","author":"Jackson Graham","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1126\/scitranslmed.aag1257","article-title":"Prion Detection in the Plasma of Pre-symptomatic Blood Donors and Symptomatic Subjects with Variant Creutzfeldt\u2013Jakob disease","volume":"8","author":"Bougard","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1315200","article-title":"A test for Creutzfeldt\u2013Jakob disease using nasal brushings","volume":"371","author":"Orru Christina","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0200","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kovacs","year":"2005","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.06.010_bb0205","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.410430618","article-title":"Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt\u2013Jakob disease","volume":"43","author":"Shibuya","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0210","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12031-011-9543-1","article-title":"Variably protease-sensitive prionopathy: a novel disease of the prion protein","volume":"45","author":"Gambetti","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.22094","article-title":"Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein","volume":"68","author":"Zou","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0220","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/aws366","article-title":"Variably protease-sensitive prionopathy in the UK: a retrospective review 1991\u20132008","volume":"136","author":"Head","year":"2013","journal-title":"Brain"},{"issue":"12","key":"10.1016\/bs.pmbts.2017.06.010_bb0225","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3201\/eid2012.140214","article-title":"Variably protease-sensitive prionopathy, a unique prion variant with inefficient transmission properties","volume":"20","author":"Diack","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0230","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1099\/vir.0.81913-0","article-title":"Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt\u2013Jakob disease","volume":"88","author":"Peden","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJM199302043280520","article-title":"Creutzfeldt\u2013Jakob disease infectivity of growth hormone derived from human pituitary glands","volume":"328","author":"Gibbs","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0240","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/brain\/awv235","article-title":"Iatrogenic CJD due to pituitary-derived hormone with genetically determined incubation times of up to 40 years","volume":"138","author":"Rudge","year":"2015","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0245","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(03)13867-6","article-title":"Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK","volume":"362","author":"Brandel","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0250","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","article-title":"Iatrogenic Creutzfeldt\u2013Jakob disease, final assessment","volume":"18","author":"Brown","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.06.010_bb0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-017-1703-0","article-title":"Amyloid-\u03b2 accumulation in the CNS in human growth hormone recipients in the UK","volume":"134","author":"Riitchie Diane","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0260","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1445-5994.1990.tb01322.x","article-title":"Creutzfeldt\u2013Jakob disease in a recipient of human pituitary-derived gonadotrophin","volume":"20","author":"Cochius","year":"1990","journal-title":"Aust N Z J Med"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0265","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/jnnp.55.11.1094","article-title":"Creutzfeldt\u2013Jakob disease in a recipient of human pituitary-derived gonadotrophion: a second case","volume":"55","author":"Cochius","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0270","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1440-1789.2008.00987.x","article-title":"Dura mater graft-associated Creutzfeldt\u2013Jakob disease in Japan: Clinicopathological and molecular characterization of the two distinct subtypes","volume":"29","author":"Yamada","year":"2009","journal-title":"Neuropathology"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0275","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1034\/j.1600-0404.2003.00199.x","article-title":"The normal population distribution of PRNP codon 129 polymorphism","volume":"108","author":"Nurmi","year":"2003","journal-title":"Acta Scand Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0280","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/jnnp.2005.073395","article-title":"Dura mater-associated Creutzfeldt\u2013Jakob disease: experience from surveillance in the UK","volume":"77","author":"Heath","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/bs.pmbts.2017.06.010_bb0285","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","article-title":"Iatrogenic Creutzfeldt\u2013Jakob disease at the millennium","volume":"55","author":"Brown","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0290","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM197403212901220","article-title":"Possible person to person transmission of Creutzfeldt\u2013Jakob disease","volume":"290","author":"Duffy","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0295","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.63.3.388","article-title":"Transmission of Creutzfeldt\u2013Jakob disease via a corneal transplant","volume":"63","author":"Heckmann","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0300","first-page":"466","article-title":"An autopsy case of Creutzfeldt\u2013Jakob disease associated with corneal transplantation [in Japanese]","volume":"8","author":"Uchiyama","year":"1994","journal-title":"Dementia"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0305","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt\u2013Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0310","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3201\/eid1308.070178","article-title":"Source of variant Creutzfeldt\u2013Jakob disease outside United Kingdom","volume":"13","author":"Sanchez-Juan","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.21583","article-title":"Variant Creutzfeldt\u2013Jakob disease in France and the United Kingdom: evidence for the same agent strain","volume":"65","author":"Brandel","year":"2009","journal-title":"Ann Neurol"},{"issue":"9261","key":"10.1016\/bs.pmbts.2017.06.010_bb0320","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(00)04236-7","article-title":"Geographical distribution of variant Creutzfeldt\u2013Jakob disease in great Britain, 1994-2000","volume":"357","author":"Cousens","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0325","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/39057","article-title":"Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent","volume":"389","author":"Bruce","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0330","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/38925","article-title":"The same prion strain causes vCJD and BSE","volume":"389","author":"Hill","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0335","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/381743a0","article-title":"BSE transmission to macaques","volume":"381","author":"Lasm\u00e9zas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0340","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1099\/vir.0.013227-0","article-title":"Transmissions of variant Creutzfeldt\u2013Jakob disease from brain and lymphoreticular tissue show uniform and conserved bovine spongiform encephalopathy-related phenotypic properties on primary and secondary passage in wild-type mice","volume":"90","author":"Ritchie","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.20708","article-title":"Risk factors for variant Creutzfeldt\u2013Jakob disease: a case\u2013control study","volume":"59","author":"Ward","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0350","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ije\/dyh374","article-title":"Risk of variant Creutzfeldt\u2013Jakob disease in France","volume":"34","author":"Chadeau-Hyam","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0355","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ije\/dyg248","article-title":"Predicting incidence of variant Creutzfeldt\u2013Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts","volume":"32","author":"Cooper","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0360","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1066838","article-title":"Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom","volume":"294","author":"Valleron","year":"2001","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0365","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1474-4422(06)70413-6","article-title":"Predicting susceptibility and incubation time of human-to-human transmission of vCJD","volume":"5","author":"Bishop","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0370","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(09)61568-3","article-title":"Variant CJD in an individual heterozygous for PRNP codon 129","volume":"374","author":"Kaski","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0375","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJMc1610003","article-title":"Variant Creutzfeldt\u2013Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129","volume":"376","author":"Mok","year":"2017","journal-title":"NEJM"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0380","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(01)05411-3","article-title":"Detection of variant Creutzfeldt\u2013Jakob disease infectivity in extraneural tissues","volume":"358","author":"Brandel","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0385","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(98)24035-9","article-title":"Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt\u2013Jakob disease","volume":"352","author":"Hilton","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0390","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/path.1580","article-title":"Prevalence of lymphoreticular prion protein accumulation in UK tissue samples","volume":"203","author":"Hilton","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0395","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9440(10)63105-7","article-title":"Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt\u2013Jakob disease: an immunohistochemical, quantitative, and biochemical study","volume":"164","author":"Head","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0400","doi-asserted-by":"crossref","first-page":"f5675","DOI":"10.1136\/bmj.f5675","article-title":"Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey","volume":"347","author":"Gill","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0405","series-title":"Summary Results of the Third National Survey of Abnormal Prion Prevalence in Archived Appendix Specimens","article-title":"Health protection report","volume":"10","author":"Public Health England","year":"2016"},{"issue":"12","key":"10.1016\/bs.pmbts.2017.06.010_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015626","article-title":"Uncertainty in the tail of the variant Creutzfeldt\u2013Jakob disease epidemic in the UK","volume":"5","author":"Garske","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.pmbts.2017.06.010_bb0415","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1038\/bdj.2007.126","article-title":"Dental treatment and risk of variant CJD\u2014a case control study","volume":"202","author":"Everington","year":"2007","journal-title":"Br Dent J"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0420","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0425","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt\u2013Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"issue":"9552","key":"10.1016\/bs.pmbts.2017.06.010_bb0430","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","article-title":"Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt\u2013Jakob disease associated with blood transfusion: a case report","volume":"368","author":"Wroe","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0435","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/vox.12371","article-title":"Creutzfeldt\u2013Jakob disease and blood transfusion: updated results of the UK transfusion medicine epidemiology review study","volume":"110","author":"Urwin","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0440","first-page":"1(3)","article-title":"Fourth case of transfusion-associated variant-CJD","author":"Health Protection Agency","year":"2007","journal-title":"Health Prot Rep"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0445","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","article-title":"Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia","volume":"16","author":"Peden","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0450","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(00)02719-7","article-title":"Transmission of BSE by blood transfusion in sheep","volume":"356","author":"Houston","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/bs.pmbts.2017.06.010_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023169","article-title":"All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD","volume":"6","author":"McCutcheon","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0460","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-6-5","article-title":"Comparative evidence for a link between Peyer's patch development and susceptibility to transmissible spongiform encephalopathies","volume":"6","author":"St","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/bs.pmbts.2017.06.010_bb0465","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.4049\/jimmunol.0802695","article-title":"The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice","volume":"183","author":"Brown","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/bs.pmbts.2017.06.010_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006075","article-title":"Increased abundance of M cells in the gut epithelium dramatically enhances oral prion disease susceptibility","volume":"12","author":"Donaldson","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0475","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2350-9-31","article-title":"Cathepsin D SNP associated with increased risk of variant Creutzfeldt\u2013Jakob disease","volume":"9","author":"Bishop","year":"2008","journal-title":"BMC Med Genet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0480","doi-asserted-by":"crossref","first-page":"1487.e21","DOI":"10.1016\/j.neurobiolaging.2011.10.011","article-title":"Genome-wide study links MTMR7 gene to variant Creutzfeldt\u2013Jakob risk","volume":"33","author":"Sanchez-Juan","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.06.010_bb0485","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2350-14-91","article-title":"Splice site SNPs of phospholipase PLCXD3 are significantly associated with variant and sporadic Creutzfeldt\u2013Jakob disease","volume":"14","author":"Bishop","year":"2013","journal-title":"BMC Med Genet"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.06.010_bb0490","first-page":"646","article-title":"Diagnosing variant Creutzfeldt\u2013Jakob disease: a retrospective analysis of the first 150 cases in the UK","volume":"82","author":"Heath","year":"2011","journal-title":"JNNP"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0495","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/bmj.324.7352.1479","article-title":"First hundred cases of variant Creutzfeldt\u2013Jakob disease: retrospective case note of early psychiatric and neurological features","volume":"342","author":"Spencer Michael","year":"2002","journal-title":"BMJ"},{"issue":"9082","key":"10.1016\/bs.pmbts.2017.06.010_bb0500","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(97)07472-2","article-title":"New variant Creutzfeldt\u2013Jakob disease: neurological features and diagnostic tests","volume":"350","author":"Zeidler","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.06.010_bb0505","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00415-002-0696-2","article-title":"Sensory features of variant Creutzfeldt\u2013Jakob disease","volume":"249","author":"McLeod","year":"2002","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.06.010_bb0510","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ana.21987","article-title":"Validation of diagnostic criteria for variant CJD","volume":"67","author":"Heath","year":"2010","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.06.010_bb0515","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","article-title":"Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples","volume":"74","author":"Bongianni","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0520","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(98)12075-5","article-title":"Investigation of variant Creutzfeldt\u2013Jakob disease and other human prion diseases with tonsil biopsy samples","volume":"353","author":"Hill","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0525","first-page":"744","article-title":"Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt\u2013Jakob disease","volume":"70","author":"Green","year":"2001","journal-title":"JNNP"},{"issue":"12","key":"10.1016\/bs.pmbts.2017.06.010_bb0530","first-page":"1408","article-title":"Elevated phosphorylated tau pT-181 in a possible PRNP codon 129MV vCJD case","volume":"81","author":"Green","year":"2010","journal-title":"JNNP"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.06.010_bb0535","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMoa1404401","article-title":"Prions in the urine of patients with variant Creutzfeldt\u2013Jakob disease","volume":"371","author":"Moda","year":"2014","journal-title":"NEJM"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0540","doi-asserted-by":"crossref","first-page":"370ra183","DOI":"10.1126\/scitranslmed.aaf6188","article-title":"Highly sensitive and specific detection of prionsin blood of variant Creutzfeldt\u2013Jakob disease patients","volume":"8","author":"Concha-Marambio","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0545","first-page":"1560","article-title":"Diagnosing variant Creutzfeldt\u2013Jakob disease with the Pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases","volume":"24","author":"Collie","year":"2003","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0550","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(06)68344-X","article-title":"The first Japanese case of variant Creutzfeldt\u2013Jakob disease showing periodic electroencephalogram","volume":"367","author":"Masahito Yamada on behalf of the Variant CJD Working Group","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0555","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.20768","article-title":"Periodic electroencephalogram complexes in a patient with variant Creutzfeldt\u2013Jakob disease","volume":"59","author":"Binelli","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2017.06.010_bb0560","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","article-title":"Creutzfeldt\u2013Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiology review study","volume":"91","author":"Hewitt","year":"2006","journal-title":"Vox Sang"}],"container-title":["Progress in Molecular Biology and Translational Science","Prion Protein"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117317300911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117317300911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T04:20:00Z","timestamp":1719375600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117317300911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128112267"],"references-count":111,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2017.06.010","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}